Dr. Ebraheim’s educational animated video describing the condition of Malignant Hyperthermia.

Malignant hyperthermia is autosomal dominant, 50% of offspring can be affected.
Dantrolene is a lifesaving drug that stops the release of calcium from the sarcoplasmic reticulum into the cell. Dantrolene blocks the calcium and decreases the intracellular calcium and stabilizes the sarcoplasmic reticulum.
You can do other things like:
• Cool the patient
• Hydrate the patient
• Get electrolyte balance
The patient will get succinylcholine, halothane, or other inhalation agents and this will trigger the initiation of malignant hyperthermia. Anesthetic agents (such as succinylcholine and halothane) basically impair the function of the sarcoplasmic reticulum and calcium hemostasis.
The condition associated with MH is usually central core disease, Duchenne Muscular Dystrophy (DMD), Arthrogryposis, or Osteogenesis Imperfecta (OI).
Malignant hyperthermia is usually diagnosed during anesthesia or by family history. There is no special, simple test for MH. You can do muscle biopsy and testing that is only done in a certain few centers. Because there is a problem in the ryanodine receptor, there will be uncontrolled release of calcium. You will get sustained muscle contraction, rigidity, spasms, muscle damage, myoglobinuria, rhabdomyolysis, and acute renal failure. Because of all this hypermetabolic activity, you will get the classic hyperthermia, that’s why they call it malignant hyperthermia (classic findings).
You can also find metabolic acidosis and hyperkalemia, which may give the patient dysrhythmia. There may be marked CO2 production. The CO2 production increases. You will have increased end-tidal CO2 (ETCO2), which can’t be explained, it is the earliest sign and probably the most specific and sensitive finding. End-tidal CO2 is what anesthesia will find. A rise in the end-tidal CO2 concentration is probably the earliest indication that the patient may have malignant hyperthermia.
How does this condition of malignant hyperthermia occur? What is going on? What is the physiology of malignant hyperthermia?
For diagnosis of malignant hyperthermia, you will probably need to know three things:
1. Sarcolemma
a. Membrane of the cell
2. T-tubule
a. Like a divot into the cell or a cliff
3. Sarcoplasmic reticulum
a. Storage for calcium
b. Container for calcium when the muscle is relaxed
c. Larger protein is embedded into the wall that serves as a calcium release channel
d. After the muscle contracts, the calcium is taken up by the sarcoplasmic reticulum (storage site)
When there is decirculation of this process because the ryanodine receptor is defective, then ryanodine triggers the release of calcium to the inside of the cell in large quantities than normal. The intracellular concentration of calcium increases substantially and will have sustained contracture of these muscles, which is how you get malignant hyperthermia.

Follow me on twitter:
[ Ссылка ]

Donate to the University of Toledo Foundation Department of Orthopaedic Surgery Endowed Chair Fund:
[ Ссылка ]

свернуть